Jones Cecilia

CIK 00018400562 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001840056

Recent Transactions

46 trades

Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-12-30−6,000→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30+6,000→ 40,326 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30$27.09/sh−2,932→ 37,394 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-09-26$36.77/sh−3,651→ 33,870 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-09-26−7,472→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-09-26+7,472→ 37,521 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24$33.54/sh−1,780→ 30,049 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-06-24−6,000→ 6,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24+6,000→ 31,829 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,681→ 25,829 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−594→ 21,843 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−2,000→ 2,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+5,667→ 27,510 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01+15,910→ 15,910 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+2,000→ 22,437 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-03-01+43,500→ 43,500 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01+12,000→ 12,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−5,667→ 11,333 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-09-26$49.03/sh−2,542→ 20,158 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-09-26−7,473→ 7,472 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-09-26+7,473→ 22,700 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-05$32.57/sh−672→ 14,840 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01+17,000→ 17,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-01+2,000→ 15,512 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01−2,000→ 4,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-03-01+60,000→ 60,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-24$21.64/sh−1,886→ 13,069 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-20+5,380→ 14,955 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2024-01-20−5,380→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-09-28$24.79/sh−2,179→ 9,575 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-09-26−7,472→ 14,945 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-09-26+7,472→ 11,754 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-30$28.36/sh−1,597→ 3,783 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-28+5,380→ 5,380 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2023-06-28−5,380→ 5,380 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-03-01+6,000→ 6,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-03-01+22,000→ 22,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2022-09-26+118,390→ 118,390 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2022-09-26+22,417→ 22,417 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2022-03-01+112,000→ 112,000 total
Tax Payment
LogicBio Therapeutics, Inc.
Common Stock
2022-01-12$2.01/sh−2,175→ 3,764 total
Exercise/Conversion
LogicBio Therapeutics, Inc.
Restricted Stock Units
2022-01-11+5,939→ 0 total
Exercise/Conversion
LogicBio Therapeutics, Inc.
Common Stock
2022-01-11+5,939→ 5,939 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2021-02-23+78,000→ 78,000 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2021-01-11+195,000→ 195,000 total
Award
LogicBio Therapeutics, Inc.
Restricted Stock Units
2021-01-11+5,939→ 5,939 total

Companies

Recent Filings

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov